Navigation Links
Dr. Paul Farmer Selected as 2011 Pro Bono Humanum Honoree by Prix Galien USA

NEW YORK, Aug. 31, 2011 /PRNewswire/ -- The Prix Galien USA Committee, responsible for awarding the most prestigious prize in biopharmaceutical research and development, announced today that Dr. Paul Farmer will be awarded the 2011 Pro Bono Humanum Award during the 5th Annual Prix Galien USA Award Ceremony.  The annual award presentation accompanies a series of other awards honoring companies who have made innovative contributions to biopharmaceutical and medical technology research and development.  The black tie ceremony will take place at the American Museum of Natural History in New York City on September 27, 2011.

The Prix Galien USA Award committee selected Dr. Farmer as this year's honoree for his work advancing community-based strategies for treating AIDS and tuberculosis among populations living in extreme poverty, as well as for mobilizing relief efforts after destructive and devastating events such as the 2010 earthquake in Haiti.

Dr. Farmer is a Kolokotrones University Professor at Harvard University and Chair of the Department of Global Health and Social Medicine at Harvard Medical School. He is Chief of the Division of Global Health Equity at Brigham and Women's Hospital in Boston, and co-founder of Partners In Health (PIH). He also serves as UN Deputy Special Envoy for Haiti, under Special Envoy Bill Clinton.

"The pioneering work that Dr. Farmer has accomplished throughout his career has left a permanent mark in the development of healthcare community-based strategies in underserved populations," said Elie Wiesel, Nobel Laureate and Prix Galien USA committee member. "As evidenced by his 30 years of compassionate and unyielding dedication in Haiti, Dr. Farmer exemplifies the spirit of The Pro Bono Humanum Award."

Each year, the Prix Galien USA Award committee awards a special Pro Bono Humanum Award to an exemplary individual, company, academic institution or a non-governmental agency that has made innovative efforts to improve the human condition. Previous winners of the award include:

2010:  President Bill Clinton and Phillipe Douste-Blazy, President of UNITAID

2009:  Dr. Barry Bloom with Dr. Jeffrey Sachs for their efforts with the Harvard School Public Health/Earth Institute to eradicate disease by understanding the immune responses to infectious diseases.

2008:  Dr. Sheldon Segal and the Population Council for their role in developing implantable hormone delivery systems

2007:  Former Merck CEO Dr. Roy Vagelos for his campaign to eradicate river blindness

The Prix Galien recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines and devices, and is considered the industry's highest accolade. Prix Galien was first established in 1970 by French pharmacist Roland Mehl and was inaugurated in the United States in September 2007. The Prix Galien USA Award committee comprises 11 individuals including Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals. For details about the Prix Galien USA Award and Committee, or to learn more about the Awards Gala, visit

Mary Heather
Porter Novelli for Prix Galien USA

SOURCE Prix Galien USA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
4. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
5. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
6. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
7. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
8. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
9. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
10. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
11. Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015   Nuance Communications, Inc. ... National Decision Support Company (NDSC) today jointly announced ... collaboration capabilities that utilize the American College of Radiology,s ... provider organizations to comply with current and emerging ... --> By combining clinical decision support, ...
(Date:11/30/2015)... , Nov. 30, 2015  Novartis will demonstrate the ... 57 th American Society of Hematology (ASH) Annual ... myelomas as well as supportive care, including key findings ... personalized cell therapies. The ASH Annual Meeting will be ... . Novartis Oncology . "We will be ...
(Date:11/30/2015)... Israel , Nov. 30, 2015  OticPharma, Ltd., ... and developing innovative therapies for ear, nose, and throat ... A. Katkin as chairman of the company,s board ... executive officer for OticPharma, Ltd.  "Keith brings a wealth ... will be able to share this experience and provide ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag Specialties, Inc. (BSI) ... for the Nutraceutical Specialties products into oral solid dosage in the over the ... “We are pleased to announce our expanded distribution agreement with ASI.” said Steve ...
(Date:11/30/2015)... ... November 30, 2015 , ... An inventor from Charlottesville, Va., is ... "My last baby had high blood pressure due to loud noises," she said, "so ... babies from noise pollution as well as radio waves and microwaves." , The baby ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its ... specializing in independent living, assisted living and all other retirement options. Support for ... awareness and research remains a top priority. , So it’s no surprise ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... of DataTrade Solutions Inc., a Healthcare IT consulting, development and support company. The ... and technical experience available within DataTrade to extend the services currently provided by ...
Breaking Medicine News(10 mins):